rs2295475

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000379.4(XDH):​c.2211C>T​(p.Ile737Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.299 in 1,614,036 control chromosomes in the GnomAD database, including 74,844 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5554 hom., cov: 34)
Exomes 𝑓: 0.30 ( 69290 hom. )

Consequence

XDH
NM_000379.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.294

Publications

30 publications found
Variant links:
Genes affected
XDH (HGNC:12805): (xanthine dehydrogenase) Xanthine dehydrogenase belongs to the group of molybdenum-containing hydroxylases involved in the oxidative metabolism of purines. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Xanthine dehydrogenase can be converted to xanthine oxidase by reversible sulfhydryl oxidation or by irreversible proteolytic modification. Defects in xanthine dehydrogenase cause xanthinuria, may contribute to adult respiratory stress syndrome, and may potentiate influenza infection through an oxygen metabolite-dependent mechanism. [provided by RefSeq, Jan 2014]
XDH Gene-Disease associations (from GenCC):
  • xanthinuria type I
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 2-31366981-G-A is Benign according to our data. Variant chr2-31366981-G-A is described in ClinVar as Benign. ClinVar VariationId is 255967.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.294 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.34 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
XDHNM_000379.4 linkc.2211C>T p.Ile737Ile synonymous_variant Exon 21 of 36 ENST00000379416.4 NP_000370.2 P47989
XDHXM_011533095.3 linkc.2208C>T p.Ile736Ile synonymous_variant Exon 21 of 36 XP_011531397.1
XDHXM_011533096.3 linkc.2211C>T p.Ile737Ile synonymous_variant Exon 21 of 29 XP_011531398.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
XDHENST00000379416.4 linkc.2211C>T p.Ile737Ile synonymous_variant Exon 21 of 36 1 NM_000379.4 ENSP00000368727.3 P47989

Frequencies

GnomAD3 genomes
AF:
0.250
AC:
38007
AN:
152120
Hom.:
5554
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0881
Gnomad AMI
AF:
0.334
Gnomad AMR
AF:
0.320
Gnomad ASJ
AF:
0.236
Gnomad EAS
AF:
0.345
Gnomad SAS
AF:
0.355
Gnomad FIN
AF:
0.321
Gnomad MID
AF:
0.223
Gnomad NFE
AF:
0.307
Gnomad OTH
AF:
0.249
GnomAD2 exomes
AF:
0.309
AC:
77569
AN:
251432
AF XY:
0.310
show subpopulations
Gnomad AFR exome
AF:
0.0823
Gnomad AMR exome
AF:
0.396
Gnomad ASJ exome
AF:
0.244
Gnomad EAS exome
AF:
0.342
Gnomad FIN exome
AF:
0.309
Gnomad NFE exome
AF:
0.304
Gnomad OTH exome
AF:
0.286
GnomAD4 exome
AF:
0.304
AC:
444675
AN:
1461796
Hom.:
69290
Cov.:
52
AF XY:
0.306
AC XY:
222484
AN XY:
727184
show subpopulations
African (AFR)
AF:
0.0755
AC:
2526
AN:
33478
American (AMR)
AF:
0.388
AC:
17363
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.243
AC:
6340
AN:
26134
East Asian (EAS)
AF:
0.352
AC:
13990
AN:
39700
South Asian (SAS)
AF:
0.347
AC:
29963
AN:
86256
European-Finnish (FIN)
AF:
0.304
AC:
16255
AN:
53414
Middle Eastern (MID)
AF:
0.232
AC:
1340
AN:
5768
European-Non Finnish (NFE)
AF:
0.306
AC:
339848
AN:
1111938
Other (OTH)
AF:
0.282
AC:
17050
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
21093
42185
63278
84370
105463
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11220
22440
33660
44880
56100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.250
AC:
38002
AN:
152240
Hom.:
5554
Cov.:
34
AF XY:
0.254
AC XY:
18933
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.0878
AC:
3649
AN:
41572
American (AMR)
AF:
0.320
AC:
4889
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.236
AC:
819
AN:
3472
East Asian (EAS)
AF:
0.345
AC:
1782
AN:
5168
South Asian (SAS)
AF:
0.354
AC:
1706
AN:
4822
European-Finnish (FIN)
AF:
0.321
AC:
3400
AN:
10586
Middle Eastern (MID)
AF:
0.218
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
0.307
AC:
20859
AN:
68010
Other (OTH)
AF:
0.250
AC:
529
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1476
2951
4427
5902
7378
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
402
804
1206
1608
2010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.287
Hom.:
29844
Bravo
AF:
0.242
Asia WGS
AF:
0.360
AC:
1251
AN:
3478
EpiCase
AF:
0.297
EpiControl
AF:
0.297

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 13, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary xanthinuria type 1 Benign:2
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Xanthinuria type II Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
0.015
DANN
Benign
0.63
PhyloP100
-0.29
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2295475; hg19: chr2-31589847; COSMIC: COSV65147622; API